July 30, 2026 | Health Outcomes, Impetus Digital, Market Access, Medical Innovation, PSP, Pharma Strategy, Value-based care, beyond the pill, digital health, digital voice, health innovation, health literacy, patient activation, patient engagement, patient support program, patientcentricity, real world data, treatment adherence
True “beyond-the-pill” strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.

The healthcare ecosystem is undergoing a fundamental, albeit gradual and sometimes painfully slow, transformation, shifting from a volume-based model—where prescription volume is prioritized—to one driven by value-based care. In this beyond-the-pill model, emphasis is placed not only on clinical outcomes, but also on real-world patient experiences. At a time when patients demand greater transparency and control over their health journey, patient engagement is no longer a nice-to-have feature or a regulatory checkmark for Pharma—it is a measurable driver of long-term commercial sustainability.
The efficacy of even the most innovative therapies can be fundamentally eroded by poor adherence, low health literacy, and disconnected care pathways. To overcome these issues, creating an environment where the patient is recognized as an active participant in their care journey, empowered to understand and manage their condition, is critical.
First and foremost, improved patient activation requires shared decision-making (SDM). SDM can be defined as a collaborative process that merges clinical evidence with the patient’s values, preferences, and lifestyle to select the optimal treatment path. For Pharma, this represents a crucial strategic shift: moving away from a prescriptive model (Pharma → Prescriber → Patient) to a supportive model that enhances HCP-patient dialogue.
This supportive approach can take many shapes, but one of the most straightforward involves developing tools and resources that enable open, balanced HCP-patient conversations. There is no limit to what this can look like, but popular examples include interactive symptom trackers, risk/benefit calculators, eDiaries, and easy-to-use digital decision aids that direct patients to pertinent information based on their individual demographic and clinical characteristics or risk factors, along with printed and digital educational materials covering the topics that matter most to patients. By investing in SDM support tools, Pharma can help ensure patients not only start therapy but also align psychologically with it, setting the foundation for long-term adherence and treatment success.
The second key factor is radical personalization. Moving beyond basic patient segmentation, true personalization means addressing the patient’s unique and complex barriers and needs. This includes social determinants of health (SDoH), health literacy gaps, logistical hurdles, and/or underlying emotional states…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Cassie Solomon, CEO of The New Group Consulting, dives into the future of innovation, digital technologies, and systems thinking in healthcare. Among many other things, we discuss how organizations can prepare…
A customer story
Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how…
Kim Shah, CEO of KnowYourMeds, explores digital health, AI, telemedicine, health literacy, and how to ensure a safe return to work amidst the ongoing COVID-19 pandemic. We also dive into…
Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,…
John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical…
Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital…
Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and…
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families.
Impetus Digital launches InSite Event™ – the most comprehensive virtual event platform for life science companies, delivered with white glove service

